رجوع
نطاق اليوم
KWD 0.95
KWD 1.00
نطاق 52 أسبوعًا
KWD 0.93
KWD 1.43
حجم التداول
5,000
متوسط 50 يوم / 200 يوم
KWD 1.01
/
KWD 1.06
الإغلاق السابق
KWD 1.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 10.9 | 0.4 |
| P/B | 1.6 | 2.9 |
| ROE % | 1.5 | 3.7 |
| Net Margin % | 9.2 | 3.9 |
| Rev Growth 5Y % | 6.6 | 10.0 |
| D/E | 0.7 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 3.557
KWD 3.487 – KWD 3.610
|
25 B | 1 |
| FY2028 |
KWD 2.632
KWD 2.581 – KWD 2.671
|
21 B | 1 |
| FY2027 |
KWD 2.441
KWD 2.393 – KWD 2.477
|
20 B | 1 |
النقاط الرئيسية
Revenue grew 6.58% annually over 5 years — modest growth
Earnings declined -94.03% over the past year
ROE of 1.46% is below average
Generating 46.55M in free cash flow
P/E of 10.92 — trading at a low valuation
Capital efficient — spends only 3.12% of revenue on capex
النمو
Revenue Growth (5Y)
6.58%
Revenue (1Y)9.03%
Earnings (1Y)-94.03%
FCF Growth (3Y)-20.92%
الجودة
Return on Equity
1.46%
ROIC14.91%
Net Margin9.16%
Op. Margin21.26%
الأمان
Debt / Equity
0.69
Current Ratio1.77
Interest Coverage3.56
التقييم
P/E Ratio
10.92
P/B Ratio1.58
EV/EBITDA5.99
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.03% | Revenue Growth (3Y) | 0.18% |
| Earnings Growth (1Y) | -94.03% | Earnings Growth (3Y) | 18.13% |
| Revenue Growth (5Y) | 6.58% | Earnings Growth (5Y) | 8.78% |
| Profitability | |||
| Revenue (TTM) | 973.01M | Net Income (TTM) | 89.16M |
| ROE | 1.46% | ROA | 6.74% |
| Gross Margin | 62.84% | Operating Margin | 21.26% |
| Net Margin | 9.16% | Free Cash Flow (TTM) | 46.55M |
| ROIC | 14.91% | FCF Growth (3Y) | -20.92% |
| Safety | |||
| Debt / Equity | 0.69 | Current Ratio | 1.77 |
| Interest Coverage | 3.56 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 10.92 | P/B Ratio | 1.58 |
| P/S Ratio | 1.00 | PEG Ratio | -0.12 |
| EV/EBITDA | 5.99 | Dividend Yield | 0.04% |
| Market Cap | 973.79M | Enterprise Value | 1.24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 973.01M | 892.41M | 969.48M | 862.36M | 754.10M |
| Net Income | 89.16M | 1.49B | 63.89M | 71.22M | 63.68M |
| EPS (Diluted) | 0.09 | 1.53 | 0.07 | 0.07 | 0.06 |
| Gross Profit | 611.40M | 572.23M | 593.52M | 521.09M | 465.65M |
| Operating Income | 206.90M | 188.13M | 188.96M | 169.35M | 145.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.32B | 1.10B | 1.22B | 1.11B | 1.05B |
| Total Liabilities | 705.75M | 581.91M | 664.14M | 587.25M | 558.53M |
| Shareholders' Equity | 616.35M | 11.59B | 552.42M | 520.52M | 490.44M |
| Total Debt | 424.54M | 311.15M | 6.24B | 330.24M | 290.25M |
| Cash & Equivalents | 158.62M | 2.38B | 1.47B | 77.10M | 61.59M |
| Current Assets | 712.15M | 12.07B | 10.67B | 579.98M | 560.98M |
| Current Liabilities | 401.22M | 6.54B | 6.62B | 479.70M | 319.96M |